Tuberculosis (BCG) Vaccine Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
Condition: Bladder Cancer Intervention: Drug: Catumaxomab Sponsor: LintonPharm Co.,Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2021 Category: Research Source Type: clinical trials
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
Condition: COVID 19 Vaccine Intervention: Biological: BCG vaccine Sponsors: Universidade Federal do Rio de Janeiro; Ministry of Science and Technology, Brazil Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2020 Category: Research Source Type: clinical trials
